Clinical efficacy of combination of pertuzumab, trastuzumab, and docetaxel for treatment of patients with HER2-positive breast cancer

BACKGROUND: This study will systematically investigate the efficacy and safety of the combination of pertuzumab, trastuzumab, and docetaxel (PTD) for treatment of patients with HER2-positive breast cancer (HER2-PBC). METHODS: A comprehensive literature search for this study will consist of 2 parts:...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Yan-cui, Ma, Ying, An, Ning, Sun, Ping, Wang, Ying, Sun, Cheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
3700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6756723/
https://www.ncbi.nlm.nih.gov/pubmed/31568001
http://dx.doi.org/10.1097/MD.0000000000017262

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6756723/
https://www.ncbi.nlm.nih.gov/pubmed/31568001
http://dx.doi.org/10.1097/MD.0000000000017262

Ejemplares similares